Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Cell Communication and Signaling : CCS
|
October 31, 2024
A non-catalytic role of IPMK is required for PLCγ1 activation in T cell receptor signaling by stabilizing the PLCγ1-Sam68 complex
Sehoon Hong, Kyurae Kim, Young-Ri Shim, et al.
Vaccines
|
September 23, 2022
An Efficacious Transgenic Strategy for Triple Knockout of Xeno-Reactive Antigen Genes GGTA1, CMAH, and B4GALNT2 from Jeju Native Pigs
Seungwon Yoon, Seulgi Lee, Chungyu Park, et al.
Neural Networks : the Official Journal of the International Neural Network Society
|
August 17, 2025
Explainable multiplex graph propagational network with multimodal neuroimage integration for dementia subtype diagnosis
Sunghong Park, Dong-Gi Lee, Juhyeon Kim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 13, 2021
TNP and its analogs: Modulation of IP6K and CYP3A4 inhibition
Seulgi Lee, Bernie Byeonghoon Park, Hongmok Kwon, et al.
Science Advances
|
April 26, 2017
Inositol polyphosphate multikinase promotes Toll-like receptor-induced inflammation by stabilizing TRAF6
Eunha Kim, Jiyoon Beon, Seulgi Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 2, 2016
Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis
Tae-Sun Lee, Joo-Young Lee, Jae Won Kyung, et al.
Cell Chemical Biology
|
May 1, 2026
Mechanism by which a linoleic acid metabolite suppresses cancer cell growth by inhibiting mTOR
Seung Ju Park, Sera Kim, Hongmok Kwon, et al.
Gastroenterology
|
May 24, 2024
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
Stephen B Hanauer, Bruce E Sands, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis
|
April 17, 2025
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
Jean-Frederic Colombel, William J Sandborn, Stefan Schreiber, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Cell Communication and Signaling : CCS
|
October 31, 2024
A non-catalytic role of IPMK is required for PLCγ1 activation in T cell receptor signaling by stabilizing the PLCγ1-Sam68 complex
Sehoon Hong, Kyurae Kim, Young-Ri Shim, et al.
Vaccines
|
September 23, 2022
An Efficacious Transgenic Strategy for Triple Knockout of Xeno-Reactive Antigen Genes GGTA1, CMAH, and B4GALNT2 from Jeju Native Pigs
Seungwon Yoon, Seulgi Lee, Chungyu Park, et al.
Neural Networks : the Official Journal of the International Neural Network Society
|
August 17, 2025
Explainable multiplex graph propagational network with multimodal neuroimage integration for dementia subtype diagnosis
Sunghong Park, Dong-Gi Lee, Juhyeon Kim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 13, 2021
TNP and its analogs: Modulation of IP6K and CYP3A4 inhibition
Seulgi Lee, Bernie Byeonghoon Park, Hongmok Kwon, et al.
Science Advances
|
April 26, 2017
Inositol polyphosphate multikinase promotes Toll-like receptor-induced inflammation by stabilizing TRAF6
Eunha Kim, Jiyoon Beon, Seulgi Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 2, 2016
Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis
Tae-Sun Lee, Joo-Young Lee, Jae Won Kyung, et al.
Cell Chemical Biology
|
May 1, 2026
Mechanism by which a linoleic acid metabolite suppresses cancer cell growth by inhibiting mTOR
Seung Ju Park, Sera Kim, Hongmok Kwon, et al.
Gastroenterology
|
May 24, 2024
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
Stephen B Hanauer, Bruce E Sands, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis
|
April 17, 2025
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
Jean-Frederic Colombel, William J Sandborn, Stefan Schreiber, et al.
Page
of 9